Challenging Therapeutics IP After Fed. Circ. Drink Can Ruling

Law360 (February 3, 2021, 5:29 PM EST) -- The U.S. Court of Appeals for the Federal Circuit's Dec. 31 opinion in Ball Metal Beverage Container Corp. v. Crown Packaging Technology Inc.,[1] though nonprecedential, raises important considerations for pharmaceutical and biologics patents, a context in which patent challengers regularly allege the indefiniteness of measurement claim terms that describe pharmacologic or physicochemical properties of the invention.

Under Ball Metal, even if a measurement term is found to allow for multiple different measurement methods that can produce different results, indefiniteness may still be avoided if the challenger cannot show that such differences "matter for determining whether or not [the] claim limitation is...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!